Executive Committee member, reporting to the CEO, for $400M+ Biotech company. Provided organizational leadership, as well as strategic and tactical guidance to Global Marketing team responsible for company's long-term plans and all upstream marketing. Additionally, supported regional downstream marketing efforts, as well as guided and focused efforts of Scientific Affairs, User Enablement, Creative Services, Corporate Branding, Digital User Experience, Trade Shows and Events teams. Launched 25+ global IVD and RUO systems, assays and reagents in the molecular diagnostic and life science spaces, leading to 84% growth and a 10+% annual CAGR over 6+ years.

Healthcare consulting service focused on driving value through expert guidance on business strategy and execution. Formerly known as ESS Consulting, work with global companies (ranging from $10M - $1B+ in annual sales) has included:- Developing Corporate and Product Strategies- Creating Turnaround Plans - Guiding Marketing Strategies and Tactics- Directing Program Launches- Identifying and Addressing Major Operational and General Management IssuesAs an example of the some of the results delivered:- Collaborated on development of a Strategic Plan and focused key initiatives that positioned company with relatively flat growth for 50+% growth over ensuing 5 years- Helped develop processes, system enhancements, training, communications, collateral, launch strategy and metrics for highly successful on-site customer storage program that launched 5 months early, exceeded enrollment targets by 56% and drove $60M in annual revenue

Led all Americas Marketing efforts for specialty GI company with 90+% market share in core PillCam franchise. Primary focus was on aligning combined 20+ person Marketing, Professional Relations and Education, and Clinical Education Consultant teams on how to best identify and meet the needs of external and internal customers through our 4 diverse product platforms, 20 new product launches, and local, regional and national in-person and distance clinical and educational support offerings. Led cross-functional global efforts focused on Crohn's disease, increasing national awareness to 90+%.

Now known as ESS Strategic Consulting, LLC.

Led all U.S. marketing efforts for $900 million V.A.C. Therapy line, including Strategy, New Product Development, Product Marketing, Channel Marketing, Branding/Communications, Health Outcomes, Market Research and Meetings/Events. Realigned the 60+ person department and $25 Marketing budget, shifting our focus to better meet the needs of our internal and external customers. Launched “next generation” technologies to help grow the business, while also overseeing the development of the product portfolio. Led a highly successful paradigm shift in the organization's competencies regarding sales force leadership capabilities, sales force targeting and selling skills, and competitive messaging.

Selected for newly created position to create structure, develop processes, drive productivity, stabilize, direct and motivate a 140 person nationwide staff. Fostered an environment that led to major improvements in teamwork between Sales, Service, Patient Financial Services, other home office departments and COPAs. Overhauled KCI's servicing approach and drove face-to-face communications, leading to dramatic increases in both customer satisfaction and employee productivity. Reduced turnover by creating a career path for our field force. All of these initiatives combined to help drive dramatic reductions in outstanding Medicare and Medicaid documents and associated unbilled dollars.

Developed strategies and operating plans that helped remold $300 million low-growth bed company into $1.5 billion high growth medical device company. Helped grow V.A.C. to be #1 product in Advanced Wound Healing – more than three times the size of #2 product. Developed portfolio management process and redirected company's portfolio, including restructuring international portfolio offerings and pricing policies, leading to major improvements in profitability. Generated, assessed and recommended licensing and acquisition opportunities. Functioned as internal consultant to Marketing, Sales, Medical and International. Positioned KCI for the most successful medical IPO in 2004 by managing point person duties and running all aspects of KCI’s Data Room, for several M&A opportunities and KCI’s 2003 recapitalization.

Integral member of Executive Management team of KCI's new technology start-up division. Grew annual sales from $1M to ~$25M per year, before division was integrated into parent company (KCI).

Office-based pharmaceutical representative promoted 2 times in less than 4 years, due to growth in territory sales and overall goals attained in previously flat to declining territories.